# A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

> **NCT07590193** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Amgen** · enrollment: 162 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** AMG 127
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07590193
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-15
- **Primary completion:** 2027-10-02
- **Final completion:** 2027-10-02
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2026-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07590193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07590193, "A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07590193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*